Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2013

View Archived Issues

Serum albumin binding proteins developed at Ablynx

Serine racemase knockout mice show decreased susceptibility to seizures

Pharma Bio partners timodepressin in Russia

NanoSmart and UCLA collaborate on new drug delivery platform

Innate Pharma presents phase I results for their anti-KIR antibody in AML

Novel radiotracers for imaging tau pathology evaluated

New antineoplastic agents synthesized at Pharminox

French researchers disclose new monoclonal antibodies for cancer and other disorders

ArQule patents new protein kinase inhibitors for cancer

Enrollment in phase II GMI-1070 trial in sickle cell disease completed

Novel thrombin inhibitors divulged by Chinese researchers

Iluvien receives marketing approval for chronic diabetic macular edema in Spain

Scientists at Kissei Pharmaceutical synthesize new SGLT2 inhibitors

Xencor receives milestone payment from Janssen for Xtend antibody

Boehringer Ingelheim enrolls patients in phase III HCVerso program

Medicago signs loan agreement with major pharmaceutical company

Siemens presents early clinical results for [18F]-T-807

Kyorin and Daiichi Sankyo terminate imidafenacin agreement in Brazil

Emergent BioSolutions begins phase II trial of NuThrax anthrax vaccine

Data and safety monitoring board clears way to completion for SyNAPSe trial

European CHMP hands down negative opinion for Raxone MAA

FDA approves first patch for treatment of migraine

European CHMP set to discuss MAA for defibrotide

Omeros' CRA technology identifies small molecules for Class B GPCR

Phase I study of KPT-330 opens to patients with AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...